emovis by FutureMeds’ Post

View organization page for emovis by FutureMeds, graphic

1,546 followers

🏡 emovis Homecare Visits: Expanding Possibilities in Clinical Research 🌐 Embracing innovation in clinical trials opens doors to a more inclusive and patient-centric approach. Here's why incorporating homecare visits into your study design could be a game-changer: 1️⃣ **Reach Diverse Patient Populations:**   - Include seriously ill patients with limited mobility.   - Reach those with rare diseases residing far from study centers.   - Accommodate young participants, minimizing travel-related burdens. 2️⃣ **Wider Patient Recruitment:**   - Overcome geographical barriers and tap into a larger pool of eligible participants.   - Ensure that distance doesn't limit the diversity of your study population. 3️⃣ **Enhanced Compliance:**   - Long journeys can deter patient participation.   - Homecare visits promote higher compliance by eliminating travel constraints. 4️⃣ **Patient-Centric Retention:**   - Provide a comprehensive customer service experience.   - Improve retention rates by prioritizing patient comfort and convenience. 5️⃣ **Accessible Studies for All:**   - Conduct studies for conditions where patients face significant mobility challenges.   - Break down barriers to participation for those unable to leave their homes. By leveraging emovis Homecare Visits, we're not just advancing research methodologies but ensuring that every patient, irrespective of their circumstances, can contribute to the progress of medical science. Let's make clinical trials more inclusive and impactful! 🌟 #ClinicalResearch #PatientCentricity Follow us on FutureMeds for more!

  • No alternative text description for this image

There is first (albeit still limited) evidence that improved patient experience translates into better recruitment and retention rates. In long-term outcomes studies high retention and comprehensive event capturing are essential elements in de-risking R&D investments. The home health service offers an effective solution to counteract trial fatigue especially among elderly patients with worsening medical conditions. More supportive data to come.

To view or add a comment, sign in

Explore topics